Garcia-Borreguero, Diego
Aragón, Alba Garcia
Moncada, Brian
Romero, Sofia
Granizo, Juan José
Quintas, Sonia
Castillo, María
Funding for this research was provided by:
Merck
Article History
Accepted: 15 November 2023
First Online: 21 January 2024
Declarations
:
: The study was supported by an unrestricted research grant from MSD Ltd to Diego Garcia-Borreguero.
: Dr. Garcia-Borreguero has received research grants from MSD and Roche and consultancy fees from Idorsia. Drs. Garcia Aragón, Moncada, Romero, Granizo, Quintas, and Castillo report no conflicts of interest.
: The data generated during the course of this study are available upon reasonable request. The study protocol can be viewed by contacting the corresponding author. No changes were made to the methods, including outcomes, after trial commencement.
: The study was performed at the Sleep Research Institute, in Madrid, Spain, and approved by the local institutional review board (CEIC Hospital La Princesa, Madrid) on Dec 23, 2017 (approval number: 21/2017).
: DGB conceived and designed the analysis; DGB, AG, BM, and SR collected and analyzed the data. Statistical analysis completed by JJG. All authors contributed to the analysis of data and the writing of the paper, approved the current manuscript, and accepted its submission to CNS Drugs.
: Not applicable.
: Written informed consent was obtained from all participants.
: Not applicable.